Biogen Boosts on Alzheimer’s News to Win Back Biotech Investors Biogen Boosts on Alzheimer’s News to Win Back Biotech Investors By Daniel Scott on June 20, 2021 The approval of a Biogen Inc medicine to treat Alzheimer’s disease by US authorities on Monday could rekindle investor interest in biotech and pharmaceutical stocks,…